Hinge Health is trading 11.16% up at $89.02 as investors respond to its August 4 earnings beat, raised 2026 revenue guidance, and planned $105 million Cylinder Health acquisition.
- Q2 revenue reached $212.8 million, up 53% year over year; full-year guidance rose to $856 million-$860 million.
- Analysts raised price targets on August 5.
- Activity is elevated relative to the August 6 close, with shares up from $80.08; the catalyst is company-specific, with no separate major August 7 announcement identified in available coverage.